SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Concerns about slowing consumer spending and weakening restaurant traffic are weighing on Wingstop, with traders also pointing to declining same-store sales and broader weakness across restaurant stocks. The sharp selloff has split the community between those viewing the shares as oversold and a potential value opportunity and those expecting further declines amid persistent business and valuation concerns.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

IGV is testing a long-standing resistance area, with traders divided between a breakout that would extend softwares relative strength and a rejection that could favor shorts. The wider debate centers on rotation between software and semiconductors, and whether AI will enhance established software platforms or disrupt SaaS businesses.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas strong run to fresh highs and positioning ahead of its upcoming earnings report are driving discussion, with traders citing defensive-stock demand and the companys recent growth momentum. Bulls see the pullback as a chance for the breakout to continue, while others argue the stock is stretched and vulnerable to profit-taking.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas run to fresh highs has traders focused on positioning ahead of its upcoming earnings report, with many highlighting the breakout and resilient payment activity. Others see the stock as overbought or fully valued and are cautious about a pullback or a muted reaction to results.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

FDA clearance of at-home Skyrizi induction for Crohns disease and positive Phase 3 lutikizumab results in hidradenitis suppurativa are fueling discussion of AbbVies immunology pipeline. Traders are generally upbeat about the companys momentum near highs, while some question the HS datas competitive strength and flag earnings-related volatility.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB discussion is dominated by technical trading around a choppy consolidation, with traders debating whether support will hold for another bounce or price will resume lower. Broader concerns about rates and risk-off conditions add to the cautious tone, while some traders remain bullish on a recovery.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Oracles force majeure notice concerning the Blue Owl-backed Project Jupiter data-center campus is weighing on OWL, as traders debate whether potential construction delays put financing returns or commitments at risk. Some view the notice as a warning for Blue Owl and its lenders, while others argue it does not cancel the project or change the parties financial commitments; broader private-credit redemption concerns remain part of the bearish backdrop.

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Schrodinger Inc

Discussion includes a reported milestone in Schrdingers Copernic catalyst collaboration, alongside interest in its AI-enabled drug-discovery platform and pharma partnerships. Optimists view these as signs of commercial potential, while skeptics point to weak software growth, ongoing losses, clinical setbacks, and management execution; takeover speculation remains unconfirmed.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is drawing attention amid a cybersecurity-sector rally tied to concerns that AI is creating new security risks and demand for identity protection, including controls for AI agents. Traders are celebrating the breakout and momentum, while others argue the valuation has run too far and expect a pullback.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Discussion centers on Digital Turbines recent earnings momentum and growth prospects in mobile advertising, app distribution, and AI-agent delivery to devices. Bulls see a durable growth story, while skeptics point to the stocks pullback after earnings, low trading volume, debt and dilution concerns, and uncertainty ahead of the next report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Champions Oncology Q4 2026 Earnings Call Transcript

On Monday, Champions Oncology (NASDAQ:CSBR) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensiveread more...

Champions Oncology Q3 2026 Earnings Call Transcript

Champions Oncology (NASDAQ:CSBR) released third-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensiveread more...

Full Transcript: Champions Oncology Q1 2027 Earnings Call

On Thursday, Champions Oncology (NASDAQ:CSBR) discussed first-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensiveread more...

CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth

Champions Oncology's first-quarter fiscal 2027 results record revenue and margin growth, stronger adjusted earnings and surging data-license revenues.

Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push

Champions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement and operational initiatives support progress.

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which life sciences stock offers better long-term upside? Let's dive in.

2 Microcaps With Gross Margin Catalysts

CSBR and CEPL have levers in place for Gross Margin improvement.

Zacks Initiates Coverage of Champions Oncology With Neutral Recommendation

Discover why Zacks rates Champions Oncology as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CSBR's accelerating pharmacology services and expanding data initiatives amid execution risks and commercialization timing.

Champions Oncology (NASDAQ:CSBR) Shares Cross Below 200-Day Moving Average   - What's Next?

Champions Oncology (NASDAQ:CSBR) Stock Crosses Below Two Hundred Day Moving Average - Here's What Happened...

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Champions Oncology Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$4.72
Prev Close	$4.76
Open	$4.65
Dividend Yield	0.00%
50-Day Moving Average	$4.97
Beta	0.54
Avg. Volume	14,983.24
PE Ratio	-58.85

52-Week High	$8.31
52-Week Low	$4.59
Market Capitalization	$65.7M
EPS (Annual)	-$0.085
Price to Book	16.88
Revenue Per Employee	$277,686.92

Feed

News

Sentiment

Earnings

Fundamentals

Info

CSBR Fundamentals